DXCM vs LCII · P/E 63, rev $2.50B vs P/E 16, rev $2.06B
DexCom Inc (DXCM) versus LCI Industries (LCII) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
LCI Industries (LCII) is a recreational vehicles company listed on US.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported LCII revenue for 2026-06-30 was $2.06B. Net income was $130.1M. Revenue was up 88.8% from 2026-03-31 to 2026-06-30. LCII currently screens at market cap $2.52B and trailing P/E 16.3.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. LCII currently screens at market cap $2.52B and trailing P/E 16.3.
Not investment advice. Open the DXCM and LCII stock pages for the full models.
Not investment advice.